- Price
- $362.16
- Day
- -3.30%
- Mkt Cap
- $43.48B
- 52W Range
- $163.11 – $428.88
- Volume
- 1.55M
- Beta
- 0.72
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Your 2027 Medicare Advantage premium may not budge, but something else buried in the fine print almost certainly will. What insurers quietly swap out could cost enrollees thousands of real dollars before they ever notice the trade was made.
Read full article
Avidity Partners Management LP purchased a new position in shares of Humana Inc. (NYSE: HUM) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 25,000 shares of the insurance provider's stock, valued at approximately $4,335,000. Humana accounts for 0.9% of Avidity Partners
Read full article
Millions of Medicare Advantage members will open a letter this fall that could quietly close doors they assume will always stay open. What insurers have already decided for 2027 and what enrollees do next could cost thousands of dollars or make coverage impossible to find.
Read full article
Wall Street analysts reshuffled their bets on Thursday as geopolitical fires, a Fed dissent surprise, and a brutal semiconductor selloff forced some major rating reversals across insurance, gaming, tech, and energy stocks.
Read full article
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Read full article
Humana NYSE: HUM said its 2026 performance is tracking in line with expectations, with management emphasizing planned Medicare Advantage margin expansion in 2027, progress in its Stars program and continued operating-cost reductions as key components of its path toward a sustainable pretax margin of at least 3% in 2028.
Read full article
Pre-market futures are flat-to-down ahead of today's open, with overseas turbulence in the memory chip market reverberating on domestic shores. We also see something of a hesitation in trading ahead of this afternoon's Fed decision on interest rates.
Read full article
A quarter-points rate hike has been bandied about as a possibility today.
Read full article
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read full article
Humana (HUM) came out with quarterly earnings of $7.61 per share, beating the Zacks Consensus Estimate of $6.22 per share. This compares to earnings of $6.27 per share a year ago.
Read full article
Humana cut its earnings outlook for the year, as the company continues to face earnings headwinds from lower Medicare Advantage Star Ratings for 2026.
Read full article
Humana on Wednesday beat Wall Street estimates for second-quarter earnings as the health insurer's spend on medical services was in line with expectations, but it left its annual adjusted profit forecast unchanged.
Read full article